Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolin C Hack

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|September 1, 2012
Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancerKatharina Heusinger, Sebastian M Jud, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|June 9, 2018
Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart DataMarius Wunderle, Gregor Olmes, Naiba Nabieva, et al.
JMIR Cancer|May 2, 2025
A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility StudyHanna Huebner, Lena A Wurmthaler, Chloë Goossens, et al.
European Journal of Medical Research|September 28, 2023
Predicting mammographic density with linear ultrasound transducersAnnika Behrens, Peter A Fasching, Eva Schwenke, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot StudyMichael P Lux, Julius Emons, Mayada R Bani, et al.
Breast Cancer Research : BCR|January 25, 2025
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markersLothar Häberle, Ramona Erber, Paul Gass, et al.
Precision Clinical Medicine|January 22, 2025
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impactHanna Huebner, Pauline Wimberger, Elena Laakmann, et al.
Breast Cancer Research : BCR|April 12, 2012
Characterizing mammographic images by using generic texture featuresLothar Häberle, Florian Wagner, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
Breast Cancer Research and Treatment|May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patientsMarius Wunderle, Paul Gass, Lothar Häberle, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|September 1, 2012
Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancerKatharina Heusinger, Sebastian M Jud, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|June 9, 2018
Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart DataMarius Wunderle, Gregor Olmes, Naiba Nabieva, et al.
JMIR Cancer|May 2, 2025
A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility StudyHanna Huebner, Lena A Wurmthaler, Chloë Goossens, et al.
European Journal of Medical Research|September 28, 2023
Predicting mammographic density with linear ultrasound transducersAnnika Behrens, Peter A Fasching, Eva Schwenke, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot StudyMichael P Lux, Julius Emons, Mayada R Bani, et al.
Breast Cancer Research : BCR|January 25, 2025
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markersLothar Häberle, Ramona Erber, Paul Gass, et al.
Precision Clinical Medicine|January 22, 2025
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impactHanna Huebner, Pauline Wimberger, Elena Laakmann, et al.
Breast Cancer Research : BCR|April 12, 2012
Characterizing mammographic images by using generic texture featuresLothar Häberle, Florian Wagner, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
Breast Cancer Research and Treatment|May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patientsMarius Wunderle, Paul Gass, Lothar Häberle, et al.
Pageof 10